Treating Hidradenitis Suppurativa Patients with Adalimumab: a Real-Life Experience of a Tertiary Care Center in Lisboa, Portugal

Neves, JM; Cunha, N; Lencastre, A; Cabete, J

http://hdl.handle.net/10400.17/4441

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Anais Bras Dermatol 2022 816.pdf		487.83 KB	Adobe PDF	Download

Send Feedback

Authors

Keywords

HSAC DER Humans Portugal Adalimumab / therapeutic use Anti-Inflammatory Agents / therapeutic use Hidradenitis Suppurativa* / drug therapy Severity of Illness Index Tertiary Care Centers

URI

http://hdl.handle.net/10400.17/4441

Citation

An Bras Dermatol . 2022 Nov-Dec;97(6):816-819. doi: 10.1016/j.abd.2021.12.004.

Publisher

Sociedade Brasileira de Dermatologia

DOI

10.1016/j.abd.2021.12.004.

Collections

DER - Artigos

Altmetrics

Full item page

Treating Hidradenitis Suppurativa Patients with Adalimumab: a Real-Life Experience of a Tertiary Care Center in Lisboa, Portugal

Authors

Advisor(s)

Abstract(s)

Description

Keywords

URI

Citation

Research Projects

Organizational Units

Journal Issue

Publisher

DOI

Collections

CC License

Altmetrics